Drug Shortage Report for MAR-CLONIDINE
| Report ID | 216012 |
| Drug Identification Number | 02524198 |
| Brand name | MAR-CLONIDINE |
| Common or Proper name | CLONIDINE |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | MARKETED |
| Active Ingredient(s) | CLONIDINE HYDROCHLORIDE |
| Strength(s) | 0.025MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 |
| ATC code | C02AC |
| ATC description | ANTIADRENERGIC AGENTS, CENTRALLY ACTING |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-02-01 |
| Actual start date | |
| Estimated end date | 2024-03-31 |
| Actual end date | 2024-03-11 |
| Shortage status | Resolved |
| Updated date | 2024-03-12 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2024-03-12 | English | Compare |
| v5 | 2024-03-11 | French | Compare |
| v4 | 2024-03-11 | English | Compare |
| v3 | 2024-02-02 | English | Compare |
| v2 | 2024-01-15 | French | Compare |
| v1 | 2024-01-15 | English | Compare |
Showing 1 to 6 of 6